These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

1187 related items for PubMed ID: 28057194

  • 21. Cost-effectiveness analysis of changing from live oral poliovirus vaccine to inactivated poliovirus vaccine in Australia.
    Tucker AW, Isaacs D, Burgess M.
    Aust N Z J Public Health; 2001 Oct; 25(5):411-6. PubMed ID: 11688618
    [Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24. Vaccine policy changes and epidemiology of poliomyelitis in the United States.
    Alexander LN, Seward JF, Santibanez TA, Pallansch MA, Kew OM, Prevots DR, Strebel PM, Cono J, Wharton M, Orenstein WA, Sutter RW.
    JAMA; 2004 Oct 13; 292(14):1696-701. PubMed ID: 15479934
    [Abstract] [Full Text] [Related]

  • 25. Remarks on the possibility of introducing the fractionated dose of the inactivated poliomyelitis vaccine in the Latin American Child Immunization Schedule.
    Arbo A, Falleiros-Arlant LH, López EL, Brea Del Castillo J, Martínez de Cuellar C, Moreno G, Rolón R, Cerda J, Eguiazú S, Study Group of Sociedad Paraguaya de Pediatría.
    Rev Chilena Infectol; 2019 Feb 13; 36(1):83-90. PubMed ID: 31095207
    [Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27. Surveillance of immunity acquired from poliovirus immunization including vaccination with the Sabin strain-derived inactivated vaccine.
    Hotta C, Ogawa T, Shirasawa H.
    Hum Vaccin Immunother; 2019 Feb 13; 15(5):1154-1159. PubMed ID: 30676843
    [Abstract] [Full Text] [Related]

  • 28. Inactivated poliovirus vaccine given alone or in a sequential schedule with bivalent oral poliovirus vaccine in Chilean infants: a randomised, controlled, open-label, phase 4, non-inferiority study.
    O'Ryan M, Bandyopadhyay AS, Villena R, Espinoza M, Novoa J, Weldon WC, Oberste MS, Self S, Borate BR, Asturias EJ, Clemens R, Orenstein W, Jimeno J, Rüttimann R, Costa Clemens SA, Chilean IPV/bOPV study group.
    Lancet Infect Dis; 2015 Nov 13; 15(11):1273-82. PubMed ID: 26318714
    [Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30. National introduction of fractional-dose inactivated polio vaccine in Sri Lanka following the global "switch".
    Gamage D, Ginige S, Palihawadana P.
    WHO South East Asia J Public Health; 2018 Sep 13; 7(2):79-83. PubMed ID: 30136665
    [Abstract] [Full Text] [Related]

  • 31. Immune response to an intercalated enhanced inactivated polio vaccine/oral polio vaccine programme in Israel: impact on the control of poliomyelitis.
    Swartz TA, Handsher R, Manor Y, Stoeckel P, Barkay A, Mendelson E, Leventhal A.
    Vaccine; 1998 Dec 13; 16(20):2090-5. PubMed ID: 9796069
    [Abstract] [Full Text] [Related]

  • 32. [Economic impact of introducing the injectable inactivated polio vaccine in Colombia].
    Alvis N, De la Hoz F, Narváez J.
    Rev Panam Salud Publica; 2010 May 13; 27(5):352-9. PubMed ID: 20602069
    [Abstract] [Full Text] [Related]

  • 33. Anomalous observations on IPV and OPV vaccination.
    John TJ.
    Dev Biol (Basel); 2001 May 13; 105():197-208. PubMed ID: 11763328
    [Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36. Humoral and mucosal immunity in infants induced by three sequential inactivated poliovirus vaccine-live attenuated oral poliovirus vaccine immunization schedules. Baltimore Area Polio Vaccine Study Group.
    Modlin JF, Halsey NA, Thoms ML, Meschievitz CK, Patriarca PA.
    J Infect Dis; 1997 Feb 13; 175 Suppl 1():S228-34. PubMed ID: 9203721
    [Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38. [Inactivated poliovirus vaccine].
    Shimizu H.
    Nihon Rinsho; 2011 Sep 13; 69(9):1604-8. PubMed ID: 21922761
    [Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40. Poliomyelitis and the control programme.
    Basu RN.
    Indian J Public Health; 1985 Sep 13; 29(3):157-61. PubMed ID: 3835132
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 60.